DAX22.462 -1,0%ESt505.331 -0,9%Top 10 Crypto12,01 -1,5%Dow41.584 -1,7%Nas17.323 -2,7%Bitcoin75.921 -2,1%Euro1,0824 ±-0,0%Öl73,38 -0,9%Gold3.083 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Tesla A1CX3T Rheinmetall 703000 NVIDIA 918422 RENK RENK73 Novo Nordisk A3EU6F Amazon 906866 Lufthansa 823212 Volkswagen (VW) vz. 766403 Mercedes-Benz Group (ex Daimler) 710000 BYD A0M4W9 HENSOLDT HAG000 Microsoft 870747 Deutsche Telekom 555750 Alphabet A (ex Google) A14Y6F thyssenkrupp 750000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Börsen mit tiefrotem Wochenausklang -- DAX geht schwächer ins Wochenende -- CureVac mit Erfolg im Patentstreit mit BioNTech -- CoreWeave-IPO, NEL, RENK, Novo Nordisk, Deutsche Bank, IONOS im Fokus
Top News
So bewegen sich die Kurse von Bitcoin, Ripple, Bitcoin Cash und Ethereum am Nachmittag So bewegen sich die Kurse von Bitcoin, Ripple, Bitcoin Cash und Ethereum am Nachmittag
US-Aktien überbewertet? - Diese Anzeichen deuten darauf hin US-Aktien überbewertet? - Diese Anzeichen deuten darauf hin
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Bis zu 3,05 % Zinsen: Jetzt die besten Tagesgeld-Angebote checken

Poxel SA Aktie

NeuKaufenVerkaufen
Poxel SA Aktien-Sparplan
0,2340 EUR +0,0155 EUR +7,09 %
STU
0,2400 EUR +0,0150 EUR +6,67 %
PAR
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.13,00 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA14M04

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINFR0012432516

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolPXXLF

Poxel SA Aktien News

DatumMeistgelesen
BusinesswirePoxel Reports Financial Results for First Half 2024 and Provides an Update on its Financial Position and Outlook
BusinesswirePoxel Reports Cash and Revenue for the Third Quarter and Nine Months 2024 and Provides Corporate Update
BusinesswirePoxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG® Royalties for USD 50 million
Wer­bungPoxel SA-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
BusinesswirePoxel Reports Revenue for the Second Quarter and First Half 2024 and Provides Corporate Update
BusinesswireSumitomo Pharma and Poxel Announce Topline Results from Post-Marketing Clinical Study on TWYMEEG® for the Treatment of Type 2 Diabetes in Japan
BusinesswirePoxel Provides an Update on Its Financial Position for the Second Quarter and First Half of 2024 and Announces the Rescheduling of Its Annual General Meeting
BusinesswirePoxel Reports Revenue for the First Quarter 2024 and Provides Corporate Update
BusinesswirePoxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results Release
BusinesswirePoxel to Report Its 2023 Annual Results by the End of April 2024
BusinesswirePoxel Reports Cash and Revenue for the Full Year 2023 and Provides Corporate Update
BusinesswirePoxel Announces its Financial Calendar for 2024
BusinesswirePoxel Provides Corporate Update
BusinesswirePoxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023
BusinesswirePoxel Announces its Participation at Upcoming Investor Conferences
BusinesswirePoxel Announces its Participation at Upcoming Scientific Conference
BusinesswirePoxel Reports Financial Results for First Half 2023 and Provides a Corporate Update
BusinesswirePoxel to Report 2023 First Half-Year Results and host a video conference on September 26, 2023
BusinesswirePoxel Reports Cash and Revenue for the Second Quarter and First Half 2023 and Provides Corporate Update
BusinesswirePoxel Announces Upcoming Participation at the H.C. Wainwright 2nd Annual Kidney Conference
BusinesswirePoxel, winner of the 2023 edition of the I-nov contest
BusinesswirePoxel Announces the Approval of a Prospectus for the Listing of New Shares on Euronext Paris
BusinesswirePoxel Announces Results from June 21, 2023 Ordinary Annual and Extraordinary General Meeting
BusinesswirePoxel Announces its Participation at Patient Association Conferences in Adrenoleukodystrophy
BusinesswirePoxel Reports Cash and Revenue for the First Quarter 2023 and Provides Corporate Update
BusinesswirePoxel Announces Notice of Its Annual General Meeting to Be Held on June 21, 2023
BusinesswirePoxel Announces TWYMEEG® (Imeglimin) Fiscal Year 2022 Sales
BusinesswirePoxel Announces Upcoming Participation at the JMP Securities Life Science Conference
BusinesswirePoxel Announces Multiple TWYMEEG® (Imeglimin) Abstracts Accepted for Oral Presentation
BusinesswirePoxel Reports Financial Results for Full Year 2022 and Provides Corporate Update
BusinesswirePoxel Announces Cash Runway Extended Through Q2 2025 Based upon Debt Restructuring Agreement and New Equity-linked Financing Facility
BusinesswirePoxel Announces Upcoming Participation at Evercore ISI’s NASH Renaissance Event
BusinesswirePoxel Announces Publication of Positive Phase 2 Results from Phase 2 NASH Trial (DESTINY-1) for PXL065 in Journal of Hepatology
BusinesswirePoxel Announces Publication in Kidney International of PXL770 Preclinical Results in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
BusinesswirePoxel Reports Cash and Revenue for the Full Year 2022 and Provides Corporate Update
BusinesswirePoxel Receives Orphan Drug Designation from the European Commission for PXL770 and PXL065 for Treatment of Adrenoleukodystrophy
BusinesswirePoxel Announces its Financial Calendar for 2023
BusinesswirePoxel Announces Drawdown of the Remaining Two Tranches of its Equity-linked Financing Facility and Provides Corporate Update
BusinesswirePoxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2022
BusinesswirePoxel Presents DESTINY-1 Phase 2 Results for PXL065 in NASH at AASLD The Liver Meeting® 2022
BusinesswirePoxel Announces Upcoming Participation at the Jefferies London Healthcare Conference
Wer­bung

Poxel SA News

Poxel SA News: auf dieser Seite finden Sie alle Poxel SA News und Nachrichten zur Poxel SA Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Poxel SA News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Poxel SA News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.